Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin J Leach

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Nature Reviews. Rheumatology|September 3, 2010
Bone: Do all Paget disease risk genes incriminate the osteoclast?Frederick R Singer, Robin J Leach
BMC Genomics|August 25, 2016
MBDDiff: an R package designed specifically for processing MBDcap-seq datasetsYuanhang Liu, Desiree Wilson, Robin J Leach, et al.
JAMA|August 5, 2014
Focusing PSA testing on detection of high-risk prostate cancers by incorporating patient preferences into decision makingIan M Thompson, Robin J Leach, Donna P Ankerst
European Urology|December 7, 2010
Prostate cancer detection: a view of the futureIan M Thompson, Robin J Leach, Donna P Ankerst
Journal of the National Cancer Institute|July 17, 2003
Prostate cancer and prostate-specific antigen: the more we know, the less we understandIan Thompson, Robin J Leach, Brad H Pollock, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 2020
Prostate Cancer Biomarker Development: National Cancer Institute's Early Detection Research Network Prostate Cancer Collaborative Group ReviewMichael A Liss, Robin J Leach, Martin G Sanda, et al.
Urology|August 27, 2010
Body mass index adjusted prostate-specific antigen and its application for prostate cancer screeningYuanyuan Liang, Donna P Ankerst, Michael Sanchez, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 13, 2002
Molecular characterization of 18p deletions: evidence for a breakpoint clusterRebecca L Schaub, Xavier T Reveles, Jacques Baillargeon, et al.
Urologic Oncology|July 16, 2020
A copy number gain on 18q present in primary prostate tumors is associated with metastatic outcomeKeith A Ashcraft, Teresa L Johnson-Pais, Dean A Troyer, et al.
Journal of Clinical Epidemiology|February 17, 2015
A simple-to-use method incorporating genomic markers into prostate cancer risk prediction tools facilitated future validationSonja Grill, Mahdi Fallah, Robin J Leach, et al.
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Nature Reviews. Rheumatology|September 3, 2010
Bone: Do all Paget disease risk genes incriminate the osteoclast?Frederick R Singer, Robin J Leach
BMC Genomics|August 25, 2016
MBDDiff: an R package designed specifically for processing MBDcap-seq datasetsYuanhang Liu, Desiree Wilson, Robin J Leach, et al.
JAMA|August 5, 2014
Focusing PSA testing on detection of high-risk prostate cancers by incorporating patient preferences into decision makingIan M Thompson, Robin J Leach, Donna P Ankerst
European Urology|December 7, 2010
Prostate cancer detection: a view of the futureIan M Thompson, Robin J Leach, Donna P Ankerst
Journal of the National Cancer Institute|July 17, 2003
Prostate cancer and prostate-specific antigen: the more we know, the less we understandIan Thompson, Robin J Leach, Brad H Pollock, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 2020
Prostate Cancer Biomarker Development: National Cancer Institute's Early Detection Research Network Prostate Cancer Collaborative Group ReviewMichael A Liss, Robin J Leach, Martin G Sanda, et al.
Urology|August 27, 2010
Body mass index adjusted prostate-specific antigen and its application for prostate cancer screeningYuanyuan Liang, Donna P Ankerst, Michael Sanchez, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 13, 2002
Molecular characterization of 18p deletions: evidence for a breakpoint clusterRebecca L Schaub, Xavier T Reveles, Jacques Baillargeon, et al.
Urologic Oncology|July 16, 2020
A copy number gain on 18q present in primary prostate tumors is associated with metastatic outcomeKeith A Ashcraft, Teresa L Johnson-Pais, Dean A Troyer, et al.
Journal of Clinical Epidemiology|February 17, 2015
A simple-to-use method incorporating genomic markers into prostate cancer risk prediction tools facilitated future validationSonja Grill, Mahdi Fallah, Robin J Leach, et al.
Pageof 13